Generic medicines

Affordable and accessible treatment options for patients and healthcare providers

As the world's leading provider of generic medicines, Teva understands the importance of making safe, quality medications accessible and affordable. We believe that every one of us should have access to quality medicine that helps manage disease, fights infection, or simply improves overall health.

Around 200 million people worldwide take one of our medicines every day. 01 In Ireland one in eight prescription packs supplied to Irish pharmacies is at Teva medicine. 02 In the UK, it is one out of every six prescription packs. 03 In addition, many prescription medicines made by other companies include active pharmaceutical ingredients produced by Teva.

With generic medicines, patients typically pay less while receiving the same medicine that is in the brand name medicine prescribed by their doctors. Generic medicines cost, on average, 80–85% less than brand-name medicines. 04

Teva’s generic products support healthcare systems. Patients and healthcare providers saved hundreds of billions of euros in the last decade by choosing Teva’s prescription generic medicines over more expensive brands. 

Our global footprint is critical to ensuring that our patients have access to our medicines. Teva has the largest supply chain of any pharmaceutical company and our network of 40,000 employees and 65 global manufacturing sites work around the clock to make sure our medicines reach patients in over 60 countries across six continents. 

Every hour there is a plane in the air, a ship on the seas or a truck on the road delivering Teva’s generic medicines to pharmacies and hospitals around the world.

We are committed to creating quality, affordable medicines for more people in more places around the world. Our scientists are currently developing over 800 generic medicines 05 that aim to increase access to treatments that can improve patients’ health and save healthcare providers billions. Teva continues to strive for a healthier world.

Share this article:


View our Frequently Asked Questions about generic medicines

Learn more

Discover the positive impact of generic medicines in Ireland

Read more

References

  1. Back to contents.

    Internal analyses conducted by Global Insights, Access & Technologies estimating number of Teva consumers.
    Ref 1 dated August 2016; Ref 2 dated April 2019

  2. Back to contents.

    Teva Ireland - Data on file 

  3. Back to contents.

    Teva UK Data on File: UKMED180180 vCertification 1.2 DOF 148a 1 in 6 prescription packs

  4. Back to contents.
  5. Back to contents.

    Data source: Global Generic R&D Pipeline as of  June 2019

Date of preparation: December 2020
Reference: COB-IE-NP-00036